Cargando…
Treating COPD Patients with Inhaled Medications in the Era of COVID-19 and Beyond: Options and Rationales for Patients at Home
COVID-19 has affected millions of patients, caregivers, and clinicians around the world. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads via droplets and close contact from person to person, and there has been an increased concern regarding aerosol drug delivery due to the poten...
Autores principales: | Ari, Arzu, Blain, Karen, Soubra, Said, Hanania, Nicola A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487292/ https://www.ncbi.nlm.nih.gov/pubmed/34611397 http://dx.doi.org/10.2147/COPD.S332021 |
Ejemplares similares
-
Caring for patients with advanced COPD: beyond the inhalers…
por: Murray, Michelle A., et al.
Publicado: (2023) -
Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019) -
Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD
por: Hanania, Nicola A, et al.
Publicado: (2018) -
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
por: Janson, Christer, et al.
Publicado: (2017) -
Matching the Inhaler to the Patient in COPD
por: Peché, Rudi, et al.
Publicado: (2021)